SVRA: Savara Inc. Company Short-Term Debt
Savara Inc. (SVRA) is creating a closed therapeutic environment to combat rare lung pathologies, leveraging the drug Molgradex. Funding for the biopharmaceutical development is currently provided primarily by investment capital. The current price action with the 0.00 indicator is presented below. The primary risks are associated with obtaining BLA approval for molgramostim, while commercial uncertainties surrounding the launch of the sole product remain significant.
Metric breakdowns and analytics for Savara Pharma (SVRA)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
- net income and valuation multiples indicators:
Initial company analysis:SVRA - Savara
Investors use this indicator to assess business liquidity and financial stability during initial screening. The metric aggregates all credit obligations maturing within twelve months. For Savara Inc. (SVRA), managing these loans is critical until the company achieves pricing power in the orphan therapy market. A reduction in this burden confirms the company's ability to fund the development of unique inhalation drugs. The dynamics of these processes are clearly reflected in this chart of current debt obligations.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|UPB - Company Short-Term Debt|Short-Term Debt Volume Zenas Corp ZBIO|IMNM: Company Short-Term Debts|gossamerbio.com (GOSS) - Company Short-Term Debts|Company Current Liabilities KALV|Company Short-Term Debt SEPN|Company Short-Term Debts PVLA|Company Short-Term Debts Rigel Corp (RIGL)|Company Short-Term Debt AnaptysBio, Inc. ANAB|Company Short-Term Loans and Borrowings ATXS|enGene - Company Short-Term Debts|RAPT - Company Short-Term Debts|JBIO (aerovatetx.com) - Company Current Liabilities|Aclaris Therapeutics, Inc - Company Short-Term Loans and Borrowings|KYTX (Kyverna Therapeutics) - Company Short-Term Debts|tizianalifesciences.com (TLSA) - Short-Term Debt Volume|Company Short-Term Debt Cabaletta Bio (CABA)|Ventyx Biosciences Inc. - Company Short-Term Indebtedness|Company Short-Term Debts THTX (Theratechnologies Inc)|AVTX - Company Current Liabilities|ELDN: Company Current Liabilities|Short-Term Debt Volume agenusbio.com AGEN|Climb Bio (CLYM) - Company Short-Term Debt|ZURA - Short-Term Debt Volume|Company Current Liabilities ATYR|Company Short-Term Debt ADAG|Company Short-Term Debt ImageneBio Inc (IMA)|STTK (shattucklabs.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts EQ (Equillium)|Company Short-Term Debts Connect Biopharma Holdings CNTB|IMUX - Company Short-Term Debt|Current Liabilities ATRA|IFRX: Company Short-Term Debts|x4pharma.com - Company Short-Term Loans and Borrowings|ACET (Adicet Bio Inc.) - Company Short-Term Debts|Company Short-Term Debts Celularity Corp|Company Short-Term Debt INmune Bio Corp (INMB)|BRNS (Barinthus Biotherapeutics Corp) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Kezar Life Sciences KZR|SABS - Company Current Liabilities|Akari Therapeutics Plc - Company Short-Term Debts|ENLV - Company Short-Term Debts|QTTB (q32bio.com) - Company Current Liabilities|GeoVax Corp - Company Short-Term Loans and Borrowings|EDSA (Edesa Biotech, Inc.) - Company Short-Term Debts|ibioinc.com (IBIO) - Short-Term Debt Volume|Company Short-Term Debt Carisma Therapeutics (CARM)|Company Current Liabilities XTL Biopharmaceuticals Ltd XTLB|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|HCWB - Company Current Liabilities|APVO: Company Current Liabilities|AIM - Company Short-Term Debts|aditxt.com (ADTX) - Company Short-Term Debt|Company Short-Term Indebtedness GRI|XRTX (XORTX) - Company Short-Term Debts|Short-Term Debt Vyome Therapeutics HIND|Company Short-Term Debt Revelation Biosciences (REVB)|Short-Term Debt Volume indaptusrx.com|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Company Short-Term Debts CalciMedica Inc CALI|AFMD: Company Current Liabilities|ALLK: Company Short-Term Debt|HOOK: Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debts|Company Short-Term Debt iTeos Therapeutics, Inc.|OCEA: Company Short-Term Loans and Borrowings|Company Short-Term Debts TCBP|Company Short-Term Debts Third Harmonic Bio Inc (THRD)